Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sumant Lamba"'
Autor:
Michael E. Nassif, Sheryl L. Windsor, Kensey Gosch, Barry A. Borlaug, Mansoor Husain, Silvio E. Inzucchi, Dalane W. Kitzman, Darren K. McGuire, Bertram Pitt, Benjamin M. Scirica, Sanjiv J. Shah, Guillermo Umpierrez, Bethany A. Austin, Sumant Lamba, Taiyeb Khumri, Kavita Sharma, Mikhail N. Kosiborod
Publikováno v:
Circulation: Heart Failure.
Background: Patients with heart failure (HF) have a high burden of symptoms and physical limitations, regardless of ejection fraction (EF). Whether the benefits of SGLT2 (sodium-glucose cotransporter-2) inhibitors on these outcomes vary across the fu
Autor:
null Suzanne V. Arnold, null James A. de Lemos, null Luke Zheng, null Robert S. Rosenson, null Christie M. Ballantyne, null Shushama Alam, null Deepak L. Bhatt, null Christopher P. Cannon, null Mikhail Kosiborod, null Thomas Knickelbine, null Charles Augenbraun, null James Talano, null Faisal Wahid, null David Suh, null Ranchhod Khant, null Shamaila Aslam, null Scott Merryman, null David Herrington, null Philip Patel, null Kenneth Fox, null Sumant Lamba, null Steven Brodie, null Neil Sheth, null Kahlid Sheikh, null Allen Geltzer, null Michael Lillestol, null Kamlesh Dave, null Stanley Koch, null Steven Lupovitch, null Carlos Piniella, null Lawrence Allen, null Rakesh Vohra, null Steven Geller, null Rohit Amin, null Charles Michieli, null Philip Levin, null Nicolas Shammas, null Andrew Potler, null Vladimir Santos, null Madaiah Revana, null Ellis Lader, null David Strobl, null Denes Korpas, null Donna DeSantis, null Debra Fuchs‐Ertman, null Wael Eid, null Linda Calhoun, null Narendra Upadhyaya, null Ryan Cotter, null James Maciejko, null Paul Ziajka, null William Smith, null Eduardo Antezano, null Philip O Donnell, null Lance Sloan, null Vance Wilson, null Denise Janosik, null James Kmetzo, null Chrisette Dharma, null Darshan Godkar, null Philip Nicol, null Micheal Hong, null Catherine Popkin, null Rajesh Patel, null Abelardo Vargas, null Minesh Patel, null Vikas Desai, null Yunsheng Ma, null Robert Block, null Louis Hiotis, null Colby Grossman, null Ahmed Arif, null Seth Baum, null Carlos Sotolongo, null Rebecca Jordan, null Paul Thompson, null Mark Napoli, null Robert Davidson, null Hugh Durrence, null Karen Aspry, null Randall Miller, null David M Headley, null Raymond Little, null Carl R Meisner, null Richard Powell, null Eliot Moon, null Kul Aggarwal, null Mark Turner, null Idalia Acosta, null Martin Schear, null Robert Harris, null Robert Lending, null Abraham Salacata, null Vicki Kalen, null C David Bird, null Caroline Mbogua, null Yamirka Duardo‐Guerra, null Deirdre McMullen, null Hessam Aazami, null Charles Lovell, null Robert Busch, null Marek Janout, null Lawrence Alwine, null Kim Barbel Johnson, null Svjetlana Dziko, null John Larry, null Joseph Cherian, null Gregory Allen, null Faye Vargas, null Stuart Zarich, null Armando Ropero‐Cartier, null Milroy Samuel, null Sandeep Khurana, null Lilia Rodriguez Ables, null Marisela Gonzalez, null Gregston Nelson, null Lester de Leon, null Luis Martinez, null Francisco Badar, null Thomas Phiambolis, null Naseem Jaffrani, null John Eck, null Brett Nowlan, null Trever Martin, null the GOULD Investigators
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd49e6b5679b670ba31c0c67f1e0f19a
https://doi.org/10.1111/dom.15032/v3/response1
https://doi.org/10.1111/dom.15032/v3/response1
Autor:
John J. Ryan, Michael Fong, Guillermo E. Umpierrez, Gregory D. Lewis, Sunit-Preet Chaudhry, Kavita Sharma, Chen H Chow, Manreet Kanwar, Yevgeniy Khariton, Mikhail Kosiborod, Taiyeb M. Khumri, Sadiya S. Khan, Michael E. Nassif, Sumant Lamba, Sanjiv J. Shah, Fengming Tang, Sheryl L. Windsor, Ali O. Malik, Barry A. Borlaug, Dalane W. Kitzman, Michael Pursley, Susan M Joseph, Robert Gordon, Lokesh Chandra, Barry S Clemson, Elias S. Siraj
Publikováno v:
Nature Medicine
Patients with heart failure and preserved ejection fraction (HFpEF) have a high burden of symptoms and functional limitations, and have a poor quality of life. By targeting cardiometabolic abmormalities, sodium glucose cotransporter 2 (SGLT2) inhibit
Autor:
Sumant Lamba, Merrill Thomas, Yevgeniy Khariton, Robert Gordon, Mikhail Kosiborod, John A. Spertus, John E. Brush, Philip Jones, David M. Shavelle, Rita Jermyn, Michael E. Nassif, Sheryl L. Windsor, Orvar Jonsson, Fengming Tang
Publikováno v:
Circulation: Heart Failure. 14
Autor:
Maria Rosa Costanzo, William T. Abraham, Poornima Sood, David M. Shavelle, Sumant Lamba, Marie-Elena Brett, J. Thomas Heywood, Lynne W. Stevenson, Philip D Adamson, Akshay S. Desai, Lisa D. Rathman, Nirav Raval
Publikováno v:
Circulation: Heart Failure. 14
Autor:
David M. Shavelle, Jamie M. Pelzel, Kunjan Bhatt, Sumant Lamba, Robert Gordon, Rita Jermyn, Andrew B. Civitello, Michael E. Nassif, Mikhail Kosiborod, Orvar Jonsson, Fengming Tang, Mohammed Qintar, John E. Brush, Brent C. Lampert, Sheryl L. Windsor
Publikováno v:
Circulation. 143(17)
Background: Sodium glucose cotransporter 2 inhibitors (SGLT2 inhibitors) prevent heart failure (HF) hospitalizations in patients with type 2 diabetes and improve outcomes in those with HF and reduced ejection fraction, regardless of type 2 diabetes.
Autor:
Rita Jermyn, Mohammed Qintar, Andrew B. Civitello, Brent C. Lampert, Mikhail Kosiborod, Sheryl L. Windsor, David M. Shavelle, John E. Brush, Orvar Jonsson, Fengming Tang, Jamie M. Pelzel, Sumant Lamba, Michael E. Nassif, Kunjan Bhatt, Robert Gordon
Publikováno v:
Journal of Cardiac Failure. 26:1109-1110
Introduction Sodium glucose cotransporter 2 inhibitors (SGLT2i) prevent heart failure (HF) in patients with Type 2 Diabetes (T2D), and reduce CV death or worsening HF in HF and reduced ejection fraction (HFrEF), regardless of T2D. Mechanisms of HF be
Autor:
Arvind Bhimaraj, Lynne W. Stevenson, Fareed Sheikh, Eric Eichorn, Kunjan Bhatt, Rahul Agarwal, William T. Abraham, Charisma Kumar, Rita Jermyn, J. Thomas Heywood, Rupinder Bharmi, David M. Shavelle, Sumant Lamba
Publikováno v:
Circulation. 135:1509-1517
Background: Elevated pulmonary artery (PA) pressures in patients with heart failure are associated with a high risk for hospitalization and mortality. Recent clinical trial evidence demonstrated a direct relationship between lowering remotely monitor
Autor:
Fenming Tang, Stuart D. Katz, Sumant Lamba, Guillermo E. Umpierrez, Yevgeniy Khariton, Michael E. Nassif, Sheryl L. Windsor, Silvio E. Inzucchi, Michael Fong, Bethany A. Austin, Darren K. McGuire, Bertram Pitt, Mansoor Husain, Benjamin M. Scirica, Mikhail Kosiborod
Publikováno v:
Journal of Cardiac Failure. 25:937-938
Background Three large cardiovascular outcome trials of patients with type 2 diabetes (T2D) found a reduction in hospitalizations for heart failure (HF) in patients treated with SGLT2i. However, a majority of patients in these trials did not have man
Autor:
Michael E, Nassif, Sheryl L, Windsor, Fengming, Tang, Yevgeniy, Khariton, Mansoor, Husain, Silvio E, Inzucchi, Darren K, McGuire, Bertram, Pitt, Benjamin M, Scirica, Bethany, Austin, Mark H, Drazner, Michael W, Fong, Michael M, Givertz, Robert A, Gordon, Rita, Jermyn, Stuart D, Katz, Sumant, Lamba, David E, Lanfear, Shane J, LaRue, JoAnn, Lindenfeld, Michael, Malone, Kenneth, Margulies, Robert J, Mentz, R Kannan, Mutharasan, Michael, Pursley, Guillermo, Umpierrez, Mikhail, Kosiborod
Publikováno v:
Circulation. 140(18)
Background: Outcome trials in patients with type 2 diabetes mellitus have demonstrated reduced hospitalizations for heart failure (HF) with sodium-glucose co-transporter-2 inhibitors. However, few of these patients had HF, and those that did were not